125 related articles for article (PubMed ID: 30355410)
1. Tuberculosis in children treated with second-line drugs under programmatic conditions in Lima, Peru.
Villarreal J; Alarcón V; Alarcón-Arrascue E; Moore DAJ; Heldal E; Mendoza-Ticona A
Int J Tuberc Lung Dis; 2018 Nov; 22(11):1307-1313. PubMed ID: 30355410
[TBL] [Abstract][Full Text] [Related]
2. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
3. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
[TBL] [Abstract][Full Text] [Related]
4. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
[TBL] [Abstract][Full Text] [Related]
5. Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru.
Otero L; De Orbegoso A; Navarro AF; Ríos J; Párraga T; Gotuzzo E; Seas C; Van der Stuyft P
Trop Med Int Health; 2015 Mar; 20(3):322-5. PubMed ID: 25429916
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcome in children admitted to a TB hospital in the Western Cape--the influence of HIV infection and drug resistance.
Soeters M; de Vries AM; Kimpen JL; Donald PR; Schaaf HS
S Afr Med J; 2005 Aug; 95(8):602-6. PubMed ID: 16201005
[TBL] [Abstract][Full Text] [Related]
7. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation of children with pulmonary tuberculosis: 25 years of experience in Lima, Peru.
Del Castillo-Barrientos H; Centeno-Luque G; Untiveros-Tello A; Simms B; Lecca L; Nelson AK; Lastimoso C; Shin S
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1066-73. PubMed ID: 25189554
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of treating multidrug-resistant tuberculosis.
Resch SC; Salomon JA; Murray M; Weinstein MC
PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
[TBL] [Abstract][Full Text] [Related]
10. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
[TBL] [Abstract][Full Text] [Related]
11. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.
Shah I; Shah F
Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119
[TBL] [Abstract][Full Text] [Related]
12. Use of Second-line Medications and Treatment Outcomes in Children With Tuberculosis in a Single Center From 2007 to 2018.
Chiappini E; Matucci T; Lisi C; Petrolini C; Venturini E; Tersigni C; de Martino M; Galli L
Pediatr Infect Dis J; 2019 Oct; 38(10):1027-1034. PubMed ID: 31397749
[TBL] [Abstract][Full Text] [Related]
13. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
Shen X; Li J; Gao Q; Xu B; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
[TBL] [Abstract][Full Text] [Related]
14. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.
Mor Z; Goldblatt D; Kaidar-Shwartz H; Cedar N; Rorman E; Chemtob D
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1195-201. PubMed ID: 25216833
[TBL] [Abstract][Full Text] [Related]
15. Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study.
Chiang SS; Starke JR; Miller AC; Cruz AT; Del Castillo H; Valdivia WJ; Tunque G; García F; Contreras C; Lecca L; Alarcón VA; Becerra MC
Clin Infect Dis; 2016 Oct; 63(8):1063-71. PubMed ID: 27458026
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.
Bélard S; Remppis J; Bootsma S; Janssen S; Kombila DU; Beyeme JO; Rossatanga EG; Kokou C; Osbak KK; Obiang Mba RM; Kaba HM; Traoré AN; Ehrhardt J; Bache EB; Flamen A; Rüsch-Gerdes S; Frank M; Adegnika AA; Lell B; Niemann S; Kremsner PG; Loembé MM; Alabi AS; Grobusch MP
Am J Trop Med Hyg; 2016 Aug; 95(2):472-80. PubMed ID: 27352879
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya.
Ombura IP; Onyango N; Odera S; Mutua F; Nyagol J
PLoS One; 2016; 11(10):e0163994. PubMed ID: 27711122
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
[TBL] [Abstract][Full Text] [Related]
20. The fourth national anti-tuberculosis drug resistance survey in Peru.
Quispe N; Asencios L; Obregon C; Velásquez GE; Mitnick CD; Lindeborg M; Jave H; Solari L
Int J Tuberc Lung Dis; 2020 Feb; 24(2):207-213. PubMed ID: 32127106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
